Nichtkleinzelliges Bronchialkarzinom – chirurgische Therapieoptionen in den frühen Stadien

Attila Nemeth; Godehard Friedel; Thorben Groß; Werner Spengler; Julia Hahn; Himatur Wolfer; Christian Schlensak; Volker Steger

doi:10.1055/a-2335-4292

TumorDiagnostik & Therapie, Inhaltsverzeichnis

TumorDiagnostik & Therapie 2025; 46(02): 104-108
DOI: 10.1055/a-2335-4292

Übersicht

Schwerpunkt

Nichtkleinzelliges Bronchialkarzinom – chirurgische Therapieoptionen in den frühen Stadien

Authors

Attila Nemeth
Godehard Friedel
Thorben Groß
Werner Spengler
Julia Hahn
Himatur Wolfer
Christian Schlensak
Volker Steger

Abstract

Das primäre Bronchialkarzinom stellt weltweit in Industrieländern die häufigste Todesursache bei Malignomen dar. Das nichtkleinzellige Lungenkarzinom (NSCLC) ist mit einem Anteil von etwa 85% die am häufigsten diagnostizierte Form dieser Erkrankung [1]. Ziel dieser Arbeit ist es, eine Analyse der chirurgischen Therapiemöglichkeiten im Frühstadium des NSCLC zu präsentieren, einschließlich der Indikationen für operative Eingriffe sowie der unterschiedlichen operativen Techniken.

Schlüsselwörter

NSCLC - chirurgisch - frühe Stadien - Therapiemöglichkeiten - operative Techniken

Volltext

Referenzen

Literatur
1 Ganti AK, Klein AB, Cotarla I. et al. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US. JAMA Oncol 2021; 7: 1824-1832
2 Krebsgesellschaft LO (Deutsche, Krebshilfe D, AWMF). S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Zugriff am 02. September 2024 unter: https://register.awmf.org/de/leitlinien/detail/020–007OL
3 Taylor MD, Nagji AS, Bhamidipati CM. et al. Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer. Ann Thorac Surg 2012; 93: 1813-1821
4 Agarwal M, Brahmanday G, Chmielewski GW. et al. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. Lung Cancer 2010; 68: 398-402
5 Bott MJ, Patel AP, Crabtree TD. et al. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?. Ann Thorac Surg 2015; 100: 2048-2053
6 Eberhardt WEE, Pöttgen C, Gauler TC. et al. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE). J Clin Oncol 2015; 33: 4194-4201
7 Robinson LA, Ruckdeschel JC, Wagner H. et al. Treatment of Non-small Cell Lung Cancer-Stage IIIA ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 2007; 132: 243S-265S
8 Schanne DH, Heitmann J, Guckenberger M. et al. Evolution of treatment strategies for oligometastatic NSCLC patients – A systematic review of the literature. Cancer Treat Rev 2019; 80: 101892
9 Nemeth A, Canavan ME, Zhan PL. et al. Salvage lung resection after immunotherapy is feasible and safe. JTCVS Open 2024; 20: 141-150
10 Zhang Z, Zhang Y, Feng H. et al. Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis. Eur J Cardio-Thorac Surg 2013; 44: 407-414
11 Hennon MW, DeGraaff LH, Groman A. et al. The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer. Eur J Cardio-Thorac Surg 2020; 57: 888-895
12 Dziedzic DA, Cackowski MM, Zbytniewski M. et al. The influence of the number of lymph nodes removed on the accuracy of a newly proposed N descriptor classification in patients with surgically-treated lung cancer. Surg Oncol 2021; 37: 101514
13 Shirke M, Soh V, Azmi A. et al. 598 Video-Assisted Thoracoscopic Surgery Versus Robot-Assisted Thoracoscopic Surgery in Early-Stage Lung Cancer: A Systematic Review and Meta-Analysis. Br J Surg 2023; 110: znad258.075
14 Tasoudis PT, Diehl JN, Merlo A. et al. Long-term outcomes of robotic versus video-assisted pulmonary lobectomy for non-small cell lung cancer: systematic review and meta-analysis of reconstructed patient data. J Thorac Dis 2023; 15: 5700-5713
15 Howington JA, Blum MG, Chang AC. et al. Treatment of Stage I and II Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013; 143: e278S-e313S
16 Winckelmans T, Decaluwé H, Leyn PD. et al. Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis. Eur J Cardio-Thorac Surg 2020; 57: 1051-1060
17 Dai C, Shen J, Ren Y. et al. Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study. J Clin Oncol 2016; 34: 3175-3182
18 Saji H, Okada M, Tsuboi M. et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022; 399: 1607-1617
19 Altorki N, Wang X, Kozono D. et al. Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer. N Engl J Med 2023; 388: 489-498
20 Shi Y, Wu S, Ma S. et al. Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review. Ann Surg Oncol 2022; 29: 1868-1879
21 Altorki NK, Kamel MK, Narula N. et al. Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non–Small Cell Lung Cancer. J Thorac Oncol 2016; 11: 1984-1992